Smart Portfolios LLC’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,954
Closed -$375K 104
2024
Q3
$375K Buy
12,954
+93
+0.7% +$2.71K 0.38% 80
2024
Q2
$360K Buy
12,861
+1,125
+10% +$31K 0.36% 80
2024
Q1
$326K Buy
11,736
+180
+2% +$5K 0.34% 80
2023
Q4
$320K Buy
+11,556
New +$349K 0.38% 69
2019
Q2
Sell
-4,682
Closed -$189K 157
2019
Q1
$189K Buy
4,682
+15
+0.3% +$601 0.16% 47
2018
Q4
$193K Buy
4,667
+520
+13% +$21.6K 0.15% 44
2018
Q3
$173K Hold
4,147
0.11% 51
2018
Q2
$143K Buy
4,147
+1,264
+44% +$43.2K 0.09% 56
2018
Q1
$97K Buy
+2,883
New +$99.1K 0.06% 58

Other funds holding PFE

Smart Portfolios LLC's PFE Position: Q4 2024 in Review

Smart Portfolios LLC sold out of Pfizer (PFE) in Q4 2024, closing a stake of 12,954 shares — an estimated $375K sold.

Smart Portfolios LLC first reported a position in PFE in Q1 2018 and held it in 9 quarters. The position peaked at $375K in Q3 2024. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Smart Portfolios LLC reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Smart Portfolios LLC sold 12,954 Pfizer shares in Q4 2024, an estimated $375K.
  • Smart Portfolios LLC first reported a position in Pfizer in Q1 2018 and held it in 9 quarters.
  • Smart Portfolios LLC's Pfizer position peaked at $375K in Q3 2024.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Smart Portfolios LLC's 13F filing for Q4 2024, filed 10 Feb 2025.